You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Organic USV Seaway Navigation System

    SBC: ACCURATE AUTOMATION CORPORATION            Topic: N04128

    Accurate Automation Corporation (AAC) will implement an innovative design concept/approach and specification for an Unmanned Surface Vehicle (USV) automated seaway navigation system. This generic system is applicable to a wide-range of surface craft sizes, types, and missions. Potential applications include Roboski, the ASH USV (OWL), Rigid Hull Inflatable Boats (RHIB) such as FREEDOM SENTINAL a ...

    SBIR Phase I 2004 Department of DefenseNavy
  2. Lymphocyte Targeting by Peptide-Drug Conjugates

    SBC: ADMUNEX THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term objective of this work is to design bi-functional peptide-drug conjugates that specifically target leukocytes. The peptide sequences are derived from ICAM-1 and bind to LFA-1 on activated leukocytes. The

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  3. SBIR Phase II: Microdisplays Based on III-Nitride Wide Band Gap Semiconductors

    SBC: III-N Technology, Inc            Topic: N/A

    The goal of this SBIR Phase II project is to bring the demonstrated Gallium Nitride (GaN) microdisplay technology to industrial maturity and to final commercialization levels. The project's goal will be accomplished by further optimizing the microdisplay device structural design and fabrication process based on the demonstrative results obtained in Phase I. Based on high-efficiency semiconductor m ...

    SBIR Phase I 2004 National Science Foundation
  4. Innovative and Low Cost Process to Produce Isoamyl Acetate using Metabolically Engineered E.Coli

    SBC: AgRenew, Inc.            Topic: N/A

    Natural flavor compounds find wide applications in the food, feed, cosmetic, chemical and pharmaceutical industry, and isoamyl acetate is an important flavor ester. In this research program, a low-cost process is proposed to convert glucose from renewable sources to isoamyl acetate using a high-yielding metabolically engineered E coli. Isoamyl acetate produced via chemical synthesis results in an ...

    SBIR Phase I 2004 Department of Agriculture
  5. Sterilization of Medical Devices with Atmospheric Plasma

    SBC: Atmospheric Glow Technologies            Topic: N/A

    DESCRIPTION (provided by applicant): The sterilization of complex medical devices is difficult due to narrow channels and the presence of optics and electronics. Atmospheric Glow Technologies will develop the Steriglow 210 for room temperature sterilizat

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  6. Drag Reduction and Flight Control of External Hypersonic Flows by EHD Plasma Actuators

    SBC: Atmospheric Glow Technologies            Topic: AF03233

    Atmospheric Glow Technologies proposes using its non-intrusive EHD plasma actuator for drag reduction and flight control of hypersonic vehicles. AGT's plasma actuator is comprised of a series of alternating electrodes embedded in a dielectric covering the surface of the hypersonic body. The primary objective of this Phase II effort is to demonstrate the commercial feasibility and aerodynamic enh ...

    SBIR Phase II 2004 Department of DefenseAir Force
  7. A Parametric Study of EHD Plasma Actuators for Munition Control

    SBC: Atmospheric Glow Technologies            Topic: AF04166

    The development of subsonic plasma actuators has the potential to revolutionize the flight performance of munitions. The addition of surface mounted flow controllers based on the electrical manipulation of surface plasma to aerodynamic control surfaces has the promise of offering a dynamic in-flight augmentation of the flight characteristics of the munitions. Plasma actuators, physically compr ...

    SBIR Phase I 2004 Department of DefenseAir Force
  8. Sterilizing Medical Equipment With One Atmosphere Uniform Glow Discharge Plasma

    SBC: Atmospheric Glow Technologies            Topic: N/A

    The goal of this Phase I research project is to investigate the feasibility and commercial potential of using the One Atmosphere Uniform Glow Discharge Plasma (OAUGDPTM) as a low-temperature sterilization process for medical equipment. Current sterilization technologies that pose a risk to health care workers and the environment are being phased out of use (e.g., ethylene oxide sterilization). T ...

    SBIR Phase I 2004 Environmental Protection Agency
  9. New Decontamination for Aircraft Cargo Interior

    SBC: Atmospheric Glow Technologies            Topic: AF04063

    Atmospheric Glow Technologies proposes to develop the Plasma Agent Neutralization Elimination (PLANE) System based upon its patented One Atmosphere Uniform Glow Discharge Plasma (OAUGDP) technology. When developed, this advanced design will serve as a stand-alone system for decontamination of large frame aircraft and assoicated cargo. AGT has demonstrated the success of the OAUGDP in decontamina ...

    SBIR Phase I 2004 Department of DefenseAir Force
  10. Antiatherogenic Properties of tert-Butylhydroquinone

    SBC: BIOINVENTIONS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Atherosclerosis is the underlying cause of most cardiovascular disease and considerable evidence supports the role of hypercholesterolemia as a risk factor for this disease. In preliminary work, we found that tertiary-butyl hydroquinone (TBHQ), at a dose lower than approved for human use, was effective in reducing plasma levels of both total cholesterol and tri ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government